|
An Interactive Clinical Review
Francis J. Giles, MD reviews key findings from leading scientific publications, clinical trials, and medical meetings that impact the clinical management of patients with CML and will assist participants with an evidence-based approach for the integration of emerging treatment advances into the clinical management of patients with CML.
Clinical Review of Current Treatment Strategies for Chronic Myeloid Leukemia
|
 |
Francis J. Giles, MD
Deputy Director
The Cancer Center at the UT Health Sciences Center
at San Antonio
Professor of Medicine
Chief, Division of Hematology and Medical Oncology
Director and AT&T Chair
Institute for Drug Development
San Antonio, TX
Topics include:
- Imatinib: IRIS 6-Year Update
- Clinical Resistance To Imatinib
- Dasatinib/Nilotinib: Clinical Activity
-
Future Directions In Managing Imatinib Resistance
|
Available until June 2009, this activity offers:
Physicians: 1 AMA PRA Category 1 Credit™
Nurses: 1 contact hour
Pharmacists: 1 contact hour (0.1 CEU)
[Back to top]
[Back to Activity Home]
|
